Olopatadine 0.2%
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Olopatadine 0.2%, covering 2017-08-14 to 2022-12-15. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment [Phase 4]